Navigation Links
Thoratec Announces Filing of PMA Seeking Destination Therapy Approval for HeartMate II(R)
Date:4/20/2009

t not exclusively those addressing future performance or timelines for regulatory approvals, contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements can be identified by the words, "believes," "views," "expects," "plans," "hopes," "could," "will," and other similar words. Actual results, events or performance could differ materially from these forward-looking statements based on a variety of factors, many of which are beyond Thoratec's control. Therefore, readers are cautioned not to put undue reliance on these statements. Investors are cautioned that all such statements involve risks and uncertainties, including risks related to regulatory approvals, the development of new markets including Destination Therapy, the growth of existing markets for our products, customer and physician acceptance of Thoratec products, changes in the mix of existing markets for our products, the results of enrollment in and timing of clinical trials, including the HeartMate II, the effects of FDA regulatory requirements and the effects of healthcare reimbursement and coverage policies. Forward-looking statements contained in this press release should be considered in light of these factors and those factors discussed from time to time in Thoratec's public reports filed with the Securities and Exchange Commission, such as those discussed under the heading "Risk Factors" in Thoratec's most recent annual report on Form 10-K and as may be updated in subsequent SEC filings. These forward-looking statements speak only as the date hereof. Thoratec undertakes no obligation to publicly release the results of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof, or to reflect the occurrence of unanticipated events.


'/>"/>
SOURCE Thoratec Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Thoratec Announces HeartMate II(R) PMA Will be Reviewed by FDA Advisory Panel
2. Thoratec Presentation at Bear Stearns Conference To Be Webcast
3. Thoratec Announces Appointment of Steven H. Collis to Board of Directors
4. Thoratec Presentation at JP Morgan Conference to be Webcast
5. Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History
6. Thoratec Schedules Third Quarter 2008 Conference Call, Webcast
7. Thoratec Reports 44 Percent Increase in Third Quarter Revenues
8. Thoratec Presentation at J.P. Morgan Conference to be Webcast
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
11. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... San Diego, CA (PRWEB) January 14, 2014 ... based on the products of cells grown under simulated ... an international license agreement with Suneva Medical, Inc. for ... media (CCM). , This agreement is an ...
(Date:1/14/2014)... 2014 As pet owners drew up their lists of New ... "Take better care of my furry companion." Nowadays there are pet ... carrying cases to take the little canine or feline darlings along ... to buy some pricey toys at the pet store. But anyone ...
(Date:1/14/2014)... Texas , Jan. 14, 2014 The ... and research medicinal plants and therapeutic derivatives thereof ... health professionals, and researchers about the challenges of ... http://photos.prnewswire.com/prnh/20100430/DC95601LOGO ) The Society ...
(Date:1/14/2014)... iLab Solutions, the leader in core facility management software, ... Strategy. In this role, Michelle will work with current and ... the development of iLab products. Her main goal will be ... the scientific community by offering the most advanced, user-friendly, and ...
Breaking Biology Technology:Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3New Year's Resolution: Give Pets the Gift of Top-Notch Health Care 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 2World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 3World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 4World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 5World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 6World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 7World's Largest Group of Medicinal Plant Researchers Endorses ABC-AHP-NCNPR Botanical Adulterants Program 8iLab Solutions Announces Michelle Detwiler as the New Director of Product Strategy 2
... Rapid Purification of Endotoxin-Free Plasmid DNA , ... HP Endotoxin-Free Plasmid Maxiprep,Kit offers a novel ... A patent-pending,endotoxin removal process has resulted in ... endotoxin-free DNA (≤ 0.1 EU/g).,This product delivers ...
... ,I. Description ,II. Product Components ,III. ... Protocol for Extraction of DNA from Soil ,V. ... ,VI. Quantification of Amplified products ,VII. Purification ... Contact Information , , , ,Application Guide, , I. ...
... ,I. Description ,II. Product Components ,III. ... Protocol for Extraction of DNA from Buccal Swab ... Swab ,VI. Quantification of Amplified Products ,VII. ... Application Data , References , Contact Information ...
Cached Biology Technology:Introducing,GenElute HP,Endotoxin-Free Plasmid,Maxiprep Kit 2Introducing,GenElute HP,Endotoxin-Free Plasmid,Maxiprep Kit 3Introducing,GenElute HP,Endotoxin-Free Plasmid,Maxiprep Kit 4Introducing,GenElute HP,Endotoxin-Free Plasmid,Maxiprep Kit 5Protocol for GenomePlex Whole Genome Amplification from Soil 2Protocol for GenomePlex Whole Genome Amplification from Soil 3Protocol for GenomePlex Whole Genome Amplification from Soil 4Protocol for GenomePlex Whole Genome Amplification from Soil 5Protocol for GenomePlex Whole Genome Amplification ,from Buccal Swab 2Protocol for GenomePlex Whole Genome Amplification ,from Buccal Swab 3Protocol for GenomePlex Whole Genome Amplification ,from Buccal Swab 4Protocol for GenomePlex Whole Genome Amplification ,from Buccal Swab 5Protocol for GenomePlex Whole Genome Amplification ,from Buccal Swab 6
(Date:4/24/2014)... led by Alison Allan, PhD, a scientist at Western ... breast cancer often spreads or metastasizes to the lung. ... and the number two cause of cancer-related deaths among ... chemotherapy and radiation have a high success rate, but ... treatments fail. In particular, the lung is one of ...
(Date:4/24/2014)... a simple and cheap way of making a high-powered ... high-resolution microscope. , Costing less than a cent, the ... developing countries and remote areas. , The lens fabrication ... Australian National University (ANU) Research School of Engineering, who ... of Medical Research to find ways to transform the ...
(Date:4/24/2014)... Munich have identified the structural features that enable ... and endogenous RNAs in living cells. , When ... metabolism and hijack cellular resources for the production ... viral RNA molecules that are delivered directly to ... synthesized in the host cell, and provide the ...
Breaking Biology News(10 mins):New study helps to explain why breast cancer often spreads to the lung 2Droplet lens 2Viral infections: Identifying the tell-tale patterns 2Viral infections: Identifying the tell-tale patterns 3
... gene for schizophrenia and exposed to lead during early ... consistent with schizophrenia. Scientists at Columbia University,s Mailman School ... of Medicine say their findings suggest a synergistic effect ... open an avenue to better understanding the complex gene-environment ...
... When language switching has no apparent ... the remarkable ability to switch from one language to the ... Pennsylvania State University, USA, looked at whether language switching incurs ... little difficulty in preventing such mix-ups between languages. When 26 ...
... is a well-known recreational drug, extensive scientific research has ... the last decade. Medical cannabis is often used by ... disorder, to combat pain, insomnia, lack of appetite, and ... Aviv University,s Adelson Center for the Biology of Addictive ...
Cached Biology News:Lead acts to trigger schizophrenia 2Frontiers news briefs May 30 2Frontiers news briefs May 30 3Frontiers news briefs May 30 4Low doses of THC can halt brain damage 2Low doses of THC can halt brain damage 3
...
... have moderate chemiluminescence efficiencies and the chemistry ... have the added benefit that they require ... the background signal. This benefit has been ... immunoassay applications. These compounds can also be ...
ssDNA from PCR DNA in less than 1 hour. No gels, columns, or slurries. Sequence from high quality ssDNA: clearer reads, longer runs....
Applications: Immunohistochemistry, ISH, FISH, CISH....
Biology Products: